Mayte Gil-Candel (Mayte Gil Candel, Maite Gil Candel)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 6

Top Topics

Ulcerative Colitis

Ejection Fraction

Patients With Inflammatory Bowel Disease

Top Venues

Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva

International journal of clinical pharmacy

European journal of hospital pharmacy : science and practice

This page only lists publications with an associated author ORCID identifier.

Publications

Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig, Aarón Puplá-Bartoll, Julia Bodega Azuara, Pablo Pérez-Huertas, Raul Ferrando Piqueres
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results. European journal of hospital pharmacy : science and practice (2022)
Mayte Gil-Candel, Juan José Gascón Cánovas, Elena Urbieta Sanz, Rosa Gómez Espín, Isabel Nicolás de Prado, Carles Iniesta-Navalón
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 112 (5) (2021)
Mayte Gil-Candel, Juan José Gascón Cánovas, Rosa Gómez Espín, Isabel Nicolás de Prado, Lorena Rentero Redondo, Elena Urbieta Sanz, Carles Iniesta-Navalón
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 112 (8) (2021)
Rosa Gómez Espín, Isabel Nicolás De Prado, Mayte Gil-Candel, Marta González Carrión, Lorena Rentero Redondo, Carles Iniesta-Navalón
Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 113 (2) (2021)
Carles Iniesta-Navalón, Mayte Gil-Candel, Ignacio Salar Valverde, Isabel Nicolás de Prado, Rosa Gómez Espín, Lorena Rentero Redondo
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 113 (11) (2021)
Mayte Gil-Candel, Juan José Gascón-Cánovas, Elena Urbieta-Sanz, Lorena Rentero-Redondo, María Onteniente-Candela, Carles Iniesta-Navalón
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease. International journal of clinical pharmacy 42 (2) (2020)